PSMA Primary Antibody
This gene encodes a type II transmembrane glycoprotein belonging to the M28 peptidase family. The protein acts as a glutamate carboxypeptidase on different alternative substrates, including the nutrient folate and the neuropeptide N-acetyl-l-aspartyl-l-glutamate and is expressed in a number of tissues such as prostate, central and peripheral nervous system and kidney. A mutation in this gene may be associated with impaired intestinal absorption of dietary folates, resulting in low blood folate levels and consequent hyperhomocysteinemia. Expression of this protein in the brain may be involved in a number of pathological conditions associated with glutamate excitotoxicity. In the prostate the protein is up-regulated in cancerous cells and is used as an effective diagnostic and prognostic indicator of prostate cancer. This gene likely arose from a duplication event of a nearby chromosomal region. Alternative splicing gives rise to multiple transcript variants encoding several different isoforms.
Purified antibody in PBS with 0.05% sodium azide
4°C; -20°C for long term storage
Figure 1: Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Figure 2:Western blot analysis using PSMA mAb against human PSMA (AA: extra 44-177) recombinant protein. (Expected MW is 47 kDa)
Figure 3:Western blot analysis using PSMA mAb against HEK293 (1) and PSMA (AA: extra 44-177)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 4:Western blot analysis using PSMA mouse mAb against Hela (1), MCF-7 (2), HCT116 (3), and GC-7901 (4) cell lysate.
Figure 5:Flow cytometric analysis of Hela cells using PSMA mouse mAb (green) and negative control (red).
For Research Use Only. Not for use in diagnostic procedures.